Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (3102)	5/28/1999 11:02:00 PM
From: IRWIN JAMES FRANKEL	Read Replies (1) \| Respond to of 10280

(On the CTXS thread I heard an assertion that the US Treasury's margins on dollar bills were 95%, about the same as the company's). I have heard that as well. The other part of the equation is that the issuance of currency carries no interest rate return. Thus, it amounts to an interest free loan to the federal government. This advantage becomes especially nice when the currencies are held abroad and become the principal medium of exchange and store of value. Then the foreign countries are subsidizing the US. It gives renewed meaning to being the worlds reserve currency. In this area we now battle the EMU. So far so good, we are winning. The magnitude of the benefit to the US is tens of billions per year. ij

To: Biomaven who wrote (3102)	5/30/1999 11:35:00 PM
From: jeffbas	Read Replies (2) \| Respond to of 10280

The popular press tonite (New York City CBS 11 PM news) reported that next year once a month anti-IGE shots will be available that may solve all your allergy woes. Showed some poor, sniffling sufferers and a medical practitioner that implied this could be the greatest thing since sliced bread for these folks. I am aware of the expert opinion on this thread that this is not a material, actual risk. However, Wall Street works off of perception and lets hope it is not perceived as a risk. (An analogy might by laser surgery for correcting vision problems, which in the opinion of most, including the leading laser surgery company, is not a material risk to contact lens companies -- but the market perceives that it might be and the lens stocks have been affected.)